Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials
Author:
Funder
Boehringer Ingelheim
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference19 articles.
1. A 4-year trial of tiotropium in chronic obstructive pulmonary disease;Tashkin;N. Engl. J. Med.,2008
2. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease;Casaburi;Eur. Respir. J.,2002
3. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis;Halpin;Int. J. Chronic Obstr. Pulm. Dis.,2015
4. Tiotropium Respimat inhaler and the risk of death in COPD;Wise;N. Engl. J. Med.,2013
5. One-year safety of olodaterol once daily via Respimat® in patients with GOLD 2-4 chronic obstructive pulmonary disease: results of a pre-specified pooled analysis;McGarvey;COPD,2015
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systemic Manifestations of COPD and the Impact of Dual Bronchodilation with Tiotropium/Olodaterol on Cardiac Function and Autonomic Integrity;Journal of Clinical Medicine;2024-05-16
2. Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists;Pharmacoepidemiology and Drug Safety;2022-05-13
3. Authors reply: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%;Journal of Internal Medicine;2022-01-18
4. Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%;Journal of Internal Medicine;2022-01-18
5. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results;Health Technology Assessment;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3